STARVAL

What is this medicine?

French reference leaflet: VALSARTAN ZENTIVA 160 mg, comprimé pelliculé sécable. Confirm indications in Morocco with a pharmacist.

Pharmacotherapeutic class: Angiotensin II antagonists, not associated, ATC code: C09CA03. VALSARTAN ZENTIVA contains the active substance: valsartan and belongs to the family of angiotensin II antagonists which help to control high blood pressure. Angiotensin II is a substance present in the body, which stimulates the contraction of blood vessels, leading to an increase in blood pressure. VALSARTAN ZENTIVA acts by blocking the effect of angiotensin II. This leads to a relaxation of the blood vessels and a decrease in blood pressure. VALSARTAN ZENTIVA can be used for three different conditions: · to treat high blood pressure in adult patients and in children and adolescents aged 6 to less than 18 years. High blood pressure increases the effort exerted by the heart and the arteries. In the absence of treatment, hypertension can damage the blood vessels of the brain, the heart and the kidneys and can lead to a stroke, heart failure or kidney failure. High blood pressure increases the risk of a heart attack. Lowering your blood pressure to a normal level allows for a reduction in the risk of these pathologies appearing. · for the treatment of adult patients who have recently suffered a heart attack (myocardial infarction). "Recently" here means between 12 hours and 10 days. · to treat adult patients suffering from symptomatic heart failure. VALSARTAN ZENTIVA is used when angiotensin-converting enzyme (ACE) inhibitors (another family of medicines to treat heart failure) cannot be used. VALSARTAN ZENTIVA can also be used in addition to ACE inhibitors when other medicines cannot be used for the treatment of heart failure. · Heart failure includes the following symptoms: shortness of breath and swelling of the feet and legs due to fluid accumulation. It occurs when the heart muscle fails to pump enough blood to provide the amount of blood required by the body.